Literature DB >> 28924309

Serum PSA levels in the Indian population: Is it different?

Amit Agrawal1, Shailesh Chandra Karan2.   

Abstract

BACKGROUND: Serum prostate-specific antigen (PSA) is an important tumour, marker which is widely used to trigger trans-rectal ultrasound (TRUS)-guided prostate biopsy. However, the PSA levels vary with race and ethnicity. Therefore, there is a need to have an Indian reference range.
METHODS: All adult male patients meeting the inclusion and exclusion criteria were enrolled in this study. They were subjected to assessment of serum total PSA, digital rectal examination and trans-abdominal ultrasound. If any one or more of these were found abnormal, then a TRUS-guided 12-core prostate biopsy was done. Patients who were detected to have prostatic cancer were excluded from the final analysis. The data so obtained was grouped among the following three age groups: 40-49, 50-59 and 60-70 years, and the age-specific PSA values, prostatic volume and PSA density were found.
RESULTS: A total of 1772 patients were analysed. The mean serum total PSA was 1.76 ng/ml with a standard deviation of 2.566 ng/ml. Group-wise age distribution of the mean serum total PSA was 1.22, 1.97 and 2.08 ng/ml in 40-49, 50-59 and 60-70 years age groups.
CONCLUSION: The mean total PSA and the age-specific PSA range tend to be lower in the Indians than the Western population.

Entities:  

Keywords:  Age specific PSA; Age specific serum PSA range; PSA in Indian population

Year:  2016        PMID: 28924309      PMCID: PMC5592255          DOI: 10.1016/j.mjafi.2016.10.004

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  12 in total

1.  [Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII].

Authors:  M Hara; Y Koyanagi; T Inoue; T Fukuyama
Journal:  Nihon Hoigaku Zasshi       Date:  1971-07

2.  Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer.

Authors:  H Matsuyama; Y Baba; G Yamakawa; N Yamamoto; K Naito
Journal:  Int J Urol       Date:  2000-11       Impact factor: 3.369

Review 3.  Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Authors:  T J Polascik; J E Oesterling; A W Partin
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

4.  Age-specific reference ranges for serum prostate-specific antigen.

Authors:  T D Richardson; J E Oesterling
Journal:  Urol Clin North Am       Date:  1997-05       Impact factor: 2.241

5.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

6.  Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma.

Authors:  B L Dalkin; F R Ahmann; J B Kopp
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

7.  Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population.

Authors:  Arvind P Ganpule; Mahesh R Desai; T Manohar; Sharad Bapat
Journal:  Indian J Urol       Date:  2007-04

8.  Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

Authors:  J E Oesterling; Y Kumamoto; T Tsukamoto; C J Girman; H A Guess; N Masumori; S J Jacobsen; M M Lieber
Journal:  Br J Urol       Date:  1995-03

9.  Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.

Authors:  A W Partin; S R Criley; E N Subong; H Zincke; P C Walsh; J E Oesterling
Journal:  J Urol       Date:  1996-04       Impact factor: 7.450

10.  Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

Authors:  William J Catalona; M'liss A Hudson; Peter T Scardino; Jerome P Richie; Frederick R Ahmann; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.